Sangamo Therapeutics, Inc. (SGMO) financial statements (2021 and earlier)

Company profile

Business Address 7000 MARINA BLVD
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments641362400243143209179
Cash and cash equivalents131801405022696
Short-term investments510282260193120140173
Restricted cash and investments      0
Receivables638545311
Prepaid expense    211
Other current assets      0
Other undisclosed current assets12552   
Total current assets:660405411248150213191
Noncurrent Assets
Operating lease, right-of-use asset71 
Property, plant and equipment41307931731
Long-term investments and receivables5122 1  47
Long-term investments5122 1  47
Intangible assets, net (including goodwill), including:10192952223
Goodwill43394022 2
Intangible assets, net (excluding goodwill)585355   2
Other undisclosed intangible assets, net (including goodwill)     2 
Restricted cash and investments224    
Other noncurrent assets14935000
Other undisclosed noncurrent assets 77     
Total noncurrent assets:279232180388552
TOTAL ASSETS:939638590287158217243
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:52182111689
Accounts payable13730346
Accrued liabilities19121001
Employee-related liabilities21 95333
Other undisclosed accounts payable and accrued liabilities 107411(0)
Deferred revenue92 
Deferred revenue and credits28499
Contract with customer, liability3948
Other undisclosed current liabilities 1495333
Total current liabilities:144707945132021
Noncurrent Liabilities
Long-term debt and lease obligation38      
Operating lease, liability38 
Liabilities, other than long-term debt25994117294516
Deferred revenue and credits294513
Deferred revenue245 
Contract with customer, liability81108
Deferred tax liabilities, net77   1
Deferred income tax liabilities7 
Other liabilities762    
Business combination, contingent consideration, liability      2
Other undisclosed noncurrent liabilities 4128254  
Total noncurrent liabilities:298135145548516
Total liabilities:44120522399222537
Stockholders' equity
Stockholders' equity attributable to parent498433367188136192207
Common stock1111111
Additional paid in capital1,2691,091930683576561535
Accumulated other comprehensive income (loss)5(2)(1)(0)0 (0)
Accumulated deficit(778)(657)(563)(495)(441)(369)(329)
Stockholders' equity attributable to noncontrolling interest(1)01    
Total stockholders' equity:497433367188136192207
TOTAL LIABILITIES AND EQUITY:939638590287158217243

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit:1181028437194046
Operating expenses(248)(208)(162)(93)(92)(86)(73)
Operating loss:(130)(105)(77)(56)(73)(47)(27)
Nonoperating income    100
Other nonoperating income    10 
Loss from continuing operations before equity method investments, income taxes:(130)(105)(77)(56)(72)(46)(26)
Other undisclosed income from continuing operations before income taxes91082   
Loss from continuing operations before income taxes:(121)(95)(69)(55)(72)(46)(26)
Income tax expense (benefit)(0)   06 
Net loss:(121)(95)(69)(55)(72)(41)(26)
Net income attributable to noncontrolling interest001    
Net loss available to common stockholders, diluted:(121)(95)(68)(55)(72)(41)(26)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(121)(95)(69)(55)(72)(41)(26)
Other comprehensive income (loss)8(2)(1)    
Other undisclosed comprehensive income (loss)(0)1(0)    
Comprehensive loss:(113)(96)(70)(55)(72)(41)(26)
Comprehensive income, net of tax, attributable to noncontrolling interest001    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (0)00(0)
Comprehensive loss, net of tax, attributable to parent:(113)(96)(69)(55)(72)(41)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: